推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine Through In Vivo Targeting to Antigen Presenting Cells.

DM White, S Pellett, MA Jensen… - Infection and …, 2011 - Am Soc Microbiol
Page 1. IAI00166-11 1 Rapid Immune Responses to a Botulinum Neurotoxin Hc
Subunit Vaccine Through In Vivo 1 Targeting to Antigen Presenting Cells. 2 Running
Title: Targeted BoNT subunit vaccine 3 4 5 David M. White1 ...
All 2 versions

Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in turkey

L Liang, M Döşkaya, S Juarez, A Caner… - Molecular & Cellular …, 2011 - ASBMB
Toxoplasmosis, caused by infection of the protozoan parasite Toxoplasma gondii, is associated
with mild disease in healthy individuals, whereas individuals with depressed immunity may develop
encephalitis, neurologic disorders, and other organ diseases. Women who develop acute ...
Related articles - All 3 versions

Subunit vaccine efficacy against Botulinum neurotoxin subtypes

JS Henkel, WH Tepp, A Przedpelski, RB Fritz… - Vaccine, 2011 - Elsevier
Botulinum neurotoxins (BoNT) are classified into 7 serotypes (A–G) based upon neutralization
by serotype-specific anti-sera. Several recombinant serotype-specific subunit BoNT vaccines
have been developed, including a subunit vaccine comprising the receptor binding ...

A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge

J Pallister, D Middleton, LF Wang, R Klein… - Vaccine, 2011 - Elsevier
The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), are two deadly zoonotic viruses
for which no vaccines or therapeutics have yet been approved for human or livestock use. In
14 outbreaks since 1994 HeV has been responsible for multiple fatalities in horses and ...
Cited by 1 - Related articles - All 2 versions

The case for a subunit vaccine against malaria

RF Anders - Trends in Parasitology, 2011 - Elsevier
New technologies and some disillusionment with subunit vaccines has led to increased interest
in the development of whole parasite vaccines for malaria. Instead, the current priority should
be to build on the partial success of the recombinant protein sporozoite vaccine, RTS,S. ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451